Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression (BPII-DEP-LT)
Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression: Double-Blind, Placebo-Controlled Study to Establish Efficacy and Safety
Sponsor: Douglas Mental Health University Institute
This NA trial investigates Bipolar Type II Disorder and Depression, Bipolar and is currently ongoing. Douglas Mental Health University Institute leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Mar 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Mar 2023 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Douglas Mental Health University Institute
- National Alliance for Research on Schizophrenia and Depression
For direct contact, visit the study record on ClinicalTrials.gov .